NO20065231L - Nye imidazoler - Google Patents

Nye imidazoler

Info

Publication number: NO20065231L
Authority: NO; Norway
Prior art keywords: compounds; new imidazoles; new; methods; imidazoles
Prior art date: 2004-04-16

Application number

NO20065231A

Other languages

English (en)

Norwegian (no)

Inventor

Gary Louis Bolton

Daniel Merritt Bowles

David Christopher Boyles

Jr Walter Allen Howard

Richard Henry Hutchings

Robert Michael Kennedy

William Keun-Chan Park

Yuntao Song

Bharat Kalidas Trivedi

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-04-16

Filing date

2006-11-14

Publication date

2007-01-09

2006-11-14 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

2007-01-09 Publication of NO20065231L publication Critical patent/NO20065231L/no

Links

150000002460 imidazoles Chemical class 0.000 title abstract 2
150000001875 compounds Chemical class 0.000 abstract 3
239000003112 inhibitor Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Cardiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)

NO20065231A 2004-04-16 2006-11-14 Nye imidazoler NO20065231L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US56312404P	2004-04-16	2004-04-16
US60070504P	2004-08-11	2004-08-11
PCT/US2005/012255 WO2005105079A2 (fr)	2004-04-16	2005-04-12	Nouveaux imidazoles

Publications (1)

Publication Number	Publication Date
NO20065231L true NO20065231L (no)	2007-01-09

Family

ID=35242215

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20065231A NO20065231L (no)	2004-04-16	2006-11-14	Nye imidazoler

Country Status (23)

Country	Link
US (2)	US20050239857A1 (fr)
EP (1)	EP1740549A2 (fr)
JP (1)	JP2007532653A (fr)
KR (1)	KR20060133013A (fr)
AP (1)	AP2006003766A0 (fr)
AR (1)	AR049023A1 (fr)
AU (1)	AU2005237428A1 (fr)
BR (1)	BRPI0509926A (fr)
CA (1)	CA2563222A1 (fr)
CR (1)	CR8687A (fr)
EA (1)	EA200601678A1 (fr)
EC (1)	ECSP066931A (fr)
IL (1)	IL178208A0 (fr)
MA (1)	MA28539B1 (fr)
MX (1)	MXPA06011657A (fr)
NO (1)	NO20065231L (fr)
NZ (1)	NZ550061A (fr)
PA (1)	PA8630801A1 (fr)
PE (1)	PE20060184A1 (fr)
SV (1)	SV2006002089A (fr)
TW (1)	TW200538442A (fr)
UY (1)	UY28856A1 (fr)
WO (1)	WO2005105079A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2328384T3 (es)	2004-11-23	2009-11-12	Warner-Lambert Company Llc	Derivados del acido 7-(2h-pirazol-3-il)-3,5-dihidroxi-heptanoico como inhibidores de hmg co-a reductasa para el tratamiento de la lipidemia.
WO2007042910A1 (fr) *	2005-10-14	2007-04-19	Pfizer Products Inc.	IMIDAZOLES ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE LA HMG-CoA-RÉDUCTASE
WO2007049121A1 (fr) *	2005-10-28	2007-05-03	Pfizer Products Inc.	Forme cristalline de sodium ; (3r,5r)-7-[4-benzylcarbamoyl-2-(4-fluorophenyl)-5-isopropyl-imidazol-1-yl]-3,5-dihydroxy-heptanoate
US20090227602A1 (en) *	2005-10-28	2009-09-10	John Griffin	Compositions and treatments for inhibiting kinase and/or hmg-coa reductase
WO2007107843A1 (fr) *	2006-03-22	2007-09-27	Pfizer Products Inc.	Procédés de traitement avec des inhibiteurs de la cetp
WO2008038098A1 (fr) *	2006-09-25	2008-04-03	Pfizer Products Inc.	Forme cristalline de l'acide 7[5-cyclopropyl)-4-o-fluorobenzylcarbamoyl)-2-(4-fluorophényl)-imidazol-1-yl]-3r,5r-dihydroxyheptanoïque
DE102007051339A1 (de) *	2007-10-26	2009-04-30	Müller-Enoch, Dieter, Prof. Dr.	Verwendung von Verbindungen der Formel A-R-X oder deren pharmazeutisch akzeptablen Salze zur Herstellung einer pharmazeutischen Zubereitung zur Behandlung und zur Vorbeugung von Dyslipidämien
DE102010012235A1 (de)	2010-03-19	2011-09-22	Acrovis Biostructures Gmbh	Imidazole
DE102010012232A1 (de)	2010-03-19	2011-09-22	Acrovis Biostructures Gmbh	Irnidazole
DE102010012233A1 (de)	2010-03-19	2011-09-22	Acrovis Biostructures Gmbh	Imidazole
WO2026006786A1 (fr) *	2024-06-28	2026-01-02	Osanni Bio, Inc.	Composé, compositions et méthodes d'utilisation associées

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4755606A (en) *	1985-05-22	1988-07-05	Sandoz Pharm. Corp.	Imidazolyl-3,5-di-(diphenyl-butylsilyloxy) carboxylic acid ester intermediates
US4808607A (en) *	1985-05-22	1989-02-28	Sandoz Pharm. Corp.	Imidazole analogs of mevalonolactone and derivatives thereof for use in inhibiting cholesterol biosynthesis and lowering blood cholesterol level
US4681893A (en) *	1986-05-30	1987-07-21	Warner-Lambert Company	Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
US5013749A (en) *	1988-10-03	1991-05-07	Glaxo Group Limited	Imidazole derivatives and their use as hypercholesterolemia and hyperlipoproteinemia agents
FI94339C (fi) *	1989-07-21	1995-08-25	Warner Lambert Co	Menetelmä farmaseuttisesti käyttökelpoisen /R-(R,R)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
US5252322A (en) *	1989-09-22	1993-10-12	The Gillette Company	Skin tanning compositions containing imidazoles
BR9609872A (pt) *	1995-07-17	1999-03-23	Warner Lambert Co	Hemi sal de cálcio de ácido (R-(RR)]-2-(4-fluorfenil-)-beta delta-diidróxi-5-(1-metiletil)-3-fenil-4- [(fenilamino) carbonil]-1H- pirrol-1heptanóico (atorvasta-tina)c ristalino
US5705145A (en) *	1996-08-21	1998-01-06	E-L Management Corp.	Skin tanning compositions and method
KR100538958B1 (ko) *	1999-09-20	2005-12-26	닛뽕소다 가부시키가이샤	4(5)-아미노-5(4)-카르복사미도이미다졸 및 그의 중간체의 제조방법

2005
- 2005-04-12 KR KR1020067021283A patent/KR20060133013A/ko not_active Ceased
- 2005-04-12 NZ NZ550061A patent/NZ550061A/en unknown
- 2005-04-12 AU AU2005237428A patent/AU2005237428A1/en not_active Abandoned
- 2005-04-12 MX MXPA06011657A patent/MXPA06011657A/es not_active Application Discontinuation
- 2005-04-12 WO PCT/US2005/012255 patent/WO2005105079A2/fr not_active Ceased
- 2005-04-12 AP AP2006003766A patent/AP2006003766A0/xx unknown
- 2005-04-12 JP JP2007508439A patent/JP2007532653A/ja not_active Ceased
- 2005-04-12 CA CA002563222A patent/CA2563222A1/fr not_active Abandoned
- 2005-04-12 EP EP05733869A patent/EP1740549A2/fr not_active Withdrawn
- 2005-04-12 EA EA200601678A patent/EA200601678A1/ru unknown
- 2005-04-12 BR BRPI0509926-9A patent/BRPI0509926A/pt not_active IP Right Cessation
- 2005-04-13 US US11/105,288 patent/US20050239857A1/en not_active Abandoned
- 2005-04-13 TW TW094111697A patent/TW200538442A/zh unknown
- 2005-04-15 PE PE2005000420A patent/PE20060184A1/es not_active Application Discontinuation
- 2005-04-15 SV SV2005002089A patent/SV2006002089A/es not_active Application Discontinuation
- 2005-04-15 PA PA20058630801A patent/PA8630801A1/es unknown
- 2005-04-15 UY UY28856A patent/UY28856A1/es not_active Application Discontinuation
- 2005-04-15 AR ARP050101510A patent/AR049023A1/es unknown
2006
- 2006-03-24 US US11/389,664 patent/US20060287378A1/en not_active Abandoned
- 2006-09-20 IL IL178208A patent/IL178208A0/en unknown
- 2006-10-12 CR CR8687A patent/CR8687A/es not_active Application Discontinuation
- 2006-10-16 EC EC2006006931A patent/ECSP066931A/es unknown
- 2006-10-16 MA MA29394A patent/MA28539B1/fr unknown
- 2006-11-14 NO NO20065231A patent/NO20065231L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ECSP066931A (es)	2006-12-20
JP2007532653A (ja)	2007-11-15
NZ550061A (en)	2009-05-31
TW200538442A (en)	2005-12-01
CA2563222A1 (fr)	2005-11-10
AP2006003766A0 (en)	2006-10-31
EP1740549A2 (fr)	2007-01-10
IL178208A0 (en)	2006-12-31
EA200601678A1 (ru)	2007-04-27
PE20060184A1 (es)	2006-04-22
UY28856A1 (es)	2005-11-30
US20060287378A1 (en)	2006-12-21
PA8630801A1 (es)	2006-03-24
KR20060133013A (ko)	2006-12-22
CR8687A (es)	2007-06-29
AU2005237428A1 (en)	2005-11-10
MA28539B1 (fr)	2007-04-03
WO2005105079A3 (fr)	2006-01-12
SV2006002089A (es)	2006-02-15
MXPA06011657A (es)	2007-04-23
BRPI0509926A (pt)	2007-09-18
US20050239857A1 (en)	2005-10-27
AR049023A1 (es)	2006-06-21
WO2005105079A2 (fr)	2005-11-10

Legal Events

Date	Code	Title	Description
2008-11-24	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
EA201070278A1 (ru)	2010-06-30	Ингибиторы гамма-секретазы
NO20071619L (no)	2007-04-25	Fremgangsmate for fremstilling av indazol forbindelse
DK1934174T3 (da)	2011-08-01	Azetidiner som MEK inhibitorer til behandling af proliferative sygdomme
MY149960A (en)	2013-11-15	4-(phenylamino)-6-oxo-1,6-dihydropyridazine-3-carboxamide derivatives as mek inhibitors for the treatment of hyperproliferative diseases
MX382352B (es)	2025-03-13	Compuestos de heteroarilo y usos de los mismos.
EA200971051A1 (ru)	2010-06-30	Ингибиторы p70 s6 киназы
CR20140215A (es)	2014-07-11	Ciclopenta (d) pirimidinas como inhibidores de la proteina cinasa akt
NO20092658L (no)	2009-09-17	New compounds
MX2009011211A (es)	2009-10-30	Indoles sustituidos en la posicion 7 inhibidores de mci-1.
ATE362932T1 (de)	2007-06-15	Azaindolverbindungen als kinaseinhibitoren
EA200970156A1 (ru)	2009-08-28	Пиридизиноновые производные
ATE479687T1 (de)	2010-09-15	Kinaseinhibitoren
AU2009236256A8 (en)	2013-12-05	Small molecule inhibitors of the pleckstrin homology domain and methods for using same
PT1940839E (pt)	2013-10-10	Inibidores de piridopirimidinona pi3k alfa
GEP20156242B (en)	2015-02-10	2-arylimidazole derivatives as pde10a enzyme inhibitors
EA200501928A1 (ru)	2006-12-29	Пирролодигидроизохинолины как ингибиторы pde10
EA201071224A1 (ru)	2011-06-30	Ингибиторы limk2, композиции, содержащие их, и способы их применения
TN2011000207A1 (en)	2012-12-17	Akt and p70 s6 kinase inhibitors
NO20081001L (no)	2008-03-25	Derivater av karboksamid som antagonister for muskarinisk reseptor
UA99787C2 (en)	2012-09-25	Lactams as beta secretase inhibitors
EA200601678A1 (ru)	2007-04-27	Новые имидазолы
NO20080839L (no)	2008-02-18	Isotopsubstituerte protonpumpeinhibitorer
EA200801145A1 (ru)	2008-10-30	Спироциклические производные хиназолина в качестве ингибиторов pde7
WO2007000337A8 (fr)	2007-04-19	Derives bicycliques utilises en tant qu'inhibiteurs de p38 kinase
CR8955A (es)	2007-08-28	Hexadecasacaridos biotinilados, su preparacion y su utilizacion